Published in Aust N Z J Med on April 01, 1999
Monoclonal gammopathy and septic arthritis. Aust N Z J Med (1999) 0.76
Monoclonal gammopathy of undetermined significance (MGUS), IgG subclass deficiency and long-term steroid therapy: unravelling the Gordian knot. Aust N Z J Med (1999) 0.75
Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double-blind, placebo-controlled trial. Am J Med (1993) 4.41
The psychiatric status of patients with the chronic fatigue syndrome. Br J Psychiatry (1990) 4.10
Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Science (1998) 3.98
A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome. Am J Med (1990) 3.42
Longitudinal study of outcome of chronic fatigue syndrome. BMJ (1994) 2.73
Person-to-person transmission of Brucella melitensis. Lancet (1991) 2.56
Synovial membrane inflammation and cytokine production in patients with early osteoarthritis. J Rheumatol (1997) 2.43
Prevalence of chronic fatigue syndrome in an Australian population. Med J Aust (1990) 2.17
What is myalgic encephalomyelitis? Lancet (1988) 2.17
Eosinophilia-myalgia syndrome associated with L-tryptophan use. Med J Aust (1990) 2.03
Long-term outcomes of vertebroplasty for osteoporotic compression fractures. J Med Imaging Radiat Oncol (2010) 2.01
Ciprofloxacin for eradication of methicillin-resistant Staphylococcus aureus colonization. Am J Med (1987) 2.00
Immunological abnormalities in the chronic fatigue syndrome. Med J Aust (1989) 1.95
A phospholipid-beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus (1992) 1.79
WAF1 retards S-phase progression primarily by inhibition of cyclin-dependent kinases. Mol Cell Biol (1997) 1.68
Accuracy and reliability of a Cosmed K4b2 portable gas analysis system. J Sci Med Sport (2004) 1.66
Variation in the biochemical/biophysical properties of mutant superoxide dismutase 1 enzymes and the rate of disease progression in familial amyotrophic lateral sclerosis kindreds. Hum Mol Genet (1999) 1.62
Iowa's National Laboratory for the study of Rural Telemedicine: a description of a work in progress. Bull Med Libr Assoc (1995) 1.62
The clinical and immunological effects of pulse methylprednisolone therapy in rheumatoid arthritis. I. Clinical effects. J Rheumatol (1988) 1.60
Strain-specific and tissue-specific expression of mouse mast cell secretory granule proteases. Proc Natl Acad Sci U S A (1994) 1.58
Differential expression of secretory granule proteases in mouse mast cells exposed to interleukin 3 and c-kit ligand. J Exp Med (1992) 1.56
The pathogenesis of pterygia. Curr Opin Ophthalmol (1999) 1.55
The DHHC domain: a new highly conserved cysteine-rich motif. Mol Cell Biochem (1999) 1.55
Toll-like receptors in ocular immunity and the immunopathogenesis of inflammatory eye disease. Br J Ophthalmol (2006) 1.53
Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: studies in yeast and neural cells. Proc Natl Acad Sci U S A (1995) 1.51
What is chronic fatigue syndrome? Heterogeneity within an international multicentre study. Aust N Z J Psychiatry (2001) 1.51
The pharmacological activity of nitroxyl: a potent vasodilator with activity similar to nitric oxide and/or endothelium-derived relaxing factor. J Pharmacol Exp Ther (1992) 1.48
Successful treatment of human immunodeficiency virus-associated Reiter's syndrome with sulfasalazine. Arthritis Rheum (1992) 1.47
Tracing the fate of limbal epithelial progenitor cells in the murine cornea. Stem Cells (2015) 1.45
Increased production of interleukin-2 (IL-2) but not soluble interleukin-2 receptors (sIL-2R) in unmedicated patients with schizophrenia and schizophreniform disorder. Psychiatry Res (1996) 1.43
Chronic fatigue syndrome: current perspectives on evaluation and management. Med J Aust (1995) 1.41
Randomized, controlled trial of the double setup tracheal tube during fibreoptic orotracheal intubation under general anaesthesia. Br J Anaesth (2004) 1.40
Treatment of refractory neurosarcoidosis with TNF-inhibitors: what lies ahead? Intern Med J (2012) 1.40
The role of alpha 1-antitrypsin deficiency in the pathogenesis of immune disorders. Clin Immunol Immunopathol (1985) 1.39
Red blood cell morphology in chronic fatigue syndrome. Lancet (1989) 1.38
Senescent cell antigen is immunologically related to band 3. Proc Natl Acad Sci U S A (1983) 1.37
Altered antigen presentation in mice lacking H2-O. Immunity (1998) 1.36
Factors associated with non-urgent utilization of Accident and Emergency services: a case-control study in Hong Kong. Soc Sci Med (2000) 1.35
Normal-pressure hydrocephalus: evaluation with cerebrospinal fluid flow measurements at MR imaging. Radiology (1996) 1.34
Chemokines in acute anterior uveitis. Curr Eye Res (1997) 1.34
IL-10 induces transcription of the gene for mouse mast cell protease-1, a serine protease preferentially expressed in mucosal mast cells of Trichinella spiralis-infected mice. J Immunol (1992) 1.33
Regulation of T lymphocyte trafficking into lymph nodes during an immune response by the chemokines macrophage inflammatory protein (MIP)-1 alpha and MIP-1 beta. J Immunol (1998) 1.30
Accuracy of common hapatic duct size in the evaluation of extrahepatic biliary obstruction. Radiology (1980) 1.30
Evaluation of four methods for detection of group B streptococcal colonization. J Clin Microbiol (1976) 1.28
A prototypical process for creating evidentiary standards for biomarkers and diagnostics. Clin Pharmacol Ther (2007) 1.28
Arthroscopic release for chronic, refractory adhesive capsulitis of the shoulder. J Bone Joint Surg Am (1996) 1.27
Psychiatric outcome in alcoholic liver transplant patients. QJM (1994) 1.26
Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans. Psychol Med (2004) 1.24
Risk factors for epilepsy in a rural area in Tanzania. A community-based case-control study. Neuroepidemiology (2001) 1.22
Direct activation of neutrophil chemiluminescence by rheumatoid sera and synovial fluid. Ann Rheum Dis (1983) 1.22
Differential expression of matrix metalloproteinases and their tissue inhibitors at the advancing pterygium head. Invest Ophthalmol Vis Sci (2000) 1.21
Nosocomial transmission of group B Streptococci in a newborn nursery. Pediatrics (1977) 1.21
Coronary subclavian steal syndrome: a rare cause of acute myocardial infarction. Singapore Med J (2007) 1.19
Analysis of the cell infiltrate and expression of matrix metalloproteinases and granzyme B in paired synovial biopsy specimens from the cartilage-pannus junction in patients with RA. Ann Rheum Dis (2001) 1.18
Diurnal variation of lymphocyte subsets identified by monoclonal antibodies. Br Med J (Clin Res Ed) (1983) 1.18
Expression of MMPs and TIMPs in human pterygia and cultured pterygium epithelial cells. Invest Ophthalmol Vis Sci (2000) 1.17
Idiopathic orbital inflammatory syndrome: clinical features and treatment outcomes. Br J Ophthalmol (2007) 1.15
Segregation of marker loci in families with an inherited paracentric insertion of chromosome 9. Am J Hum Genet (1986) 1.14
Can the chronic fatigue syndrome be defined by distinct clinical features? Psychol Med (1995) 1.13
Long-term reproducibility of ambulatory blood pressure is superior to office blood pressure in the very elderly. J Hum Hypertens (2010) 1.12
Intravenous pulse methylprednisolone in scleritis. Arch Ophthalmol (1987) 1.12
Effects of intraarticular glucocorticoids on macrophage infiltration and mediators of joint damage in osteoarthritis synovial membranes: findings in a double-blind, placebo-controlled study. Arthritis Rheum (2001) 1.12
Mast cell responses in rheumatoid synovium. Association of the MCTC subset with matrix turnover and clinical progression. Arthritis Rheum (1997) 1.10
Expression of chemokines and matrix metalloproteinases in early rheumatoid arthritis. Rheumatology (Oxford) (2001) 1.10
Active cell death in hormone-dependent tissues. Cancer Metastasis Rev (1992) 1.10
Lymphocyte subsets and inflammatory indices in synovial fluid and blood of patients with rheumatoid arthritis. J Rheumatol (1984) 1.10
Advances in lung cancer diagnosis and staging: endobronchial ultrasound. Intern Med J (2007) 1.10
Transformation of inferior vena caval thrombosis to membranous obstruction in a patient with the lupus anticoagulant. Gastroenterology (1986) 1.09
Mast cell activation and migration to lymph nodes during induction of an immune response in mice. J Clin Invest (1998) 1.09
Transcriptional regulation of the mucosal mast cell-specific protease gene, MMCP-2, by interleukin 10 and interleukin 3. J Biol Chem (1992) 1.09
The level of accuracy and agreement in measures of FEO2, FECO2 and VE between the Cosmed K4b2 portable, respiratory gas analysis system and a metabolic cart. J Sci Med Sport (2001) 1.09
Lipopolysaccharide nonresponder cells: the C3H/HeJ defect. Immunobiology (1993) 1.08
Uveitis: aetiology and disease associations in an Australian population. Aust N Z J Ophthalmol (1986) 1.08
Chemokines and T lymphocyte recruitment to lymph nodes in HIV infection. Am J Pathol (1996) 1.07
Characterization of a human fovea cDNA library and regional differential gene expression in the human retina. Genomics (1996) 1.07
Tumour-stromal interactions. Integrins and cell adhesions as modulators of mammary cell survival and transformation. Breast Cancer Res (2001) 1.06
Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts. Am J Pathol (1997) 1.06
Synovial tissue protease gene expression and joint erosions in early rheumatoid arthritis. Arthritis Rheum (2001) 1.05
Screening for prolonged fatigue syndromes: validation of the SOFA scale. Soc Psychiatry Psychiatr Epidemiol (2000) 1.04
Antigenicity, storage, and aging: physiologic autoantibodies to cell membrane and serum proteins and the senescent cell antigen. Mol Cell Biochem (1982) 1.04
Increased matrix metalloproteinases in the aqueous humor of patients and experimental animals with uveitis. Curr Eye Res (1996) 1.04
Clusterin biogenesis is altered during apoptosis in the regressing rat ventral prostate. J Biol Chem (1998) 1.03
Development, test reliability and validation of a classification for revision hip arthroplasty. J Orthop Res (2001) 1.03
Optimum dry eye classification using questionnaire responses. Adv Exp Med Biol (1998) 1.02
Pharmacokinetics, COX-2 specificity, and tolerability of supratherapeutic doses of rofecoxib in humans. Eur J Clin Pharmacol (2000) 1.02
Validity, reliability and stability of the portable Cortex Metamax 3B gas analysis system. Eur J Appl Physiol (2011) 1.02
Balance of pro- and anti-inflammatory cytokines correlates with outcome of acute experimental Pseudomonas aeruginosa keratitis. Infect Immun (2002) 1.01
Chemiluminescent response to pathogenic organisms: normal human polymorphonuclear leukocytes. Infect Immun (1984) 1.01
Bastadins relate ryanodine-sensitive and -insensitive Ca2+ efflux pathways in skeletal SR and BC3H1 cells. Am J Physiol (1997) 1.01
Three-dimensional models of four mouse mast cell chymases. Identification of proteoglycan binding regions and protease-specific antigenic epitopes. J Biol Chem (1993) 1.01
Cell-mediated immunity in patients with chronic fatigue syndrome, healthy control subjects and patients with major depression. Clin Exp Immunol (1992) 1.01
Lack of expression of the tryptase mouse mast cell protease 7 in mast cells of the C57BL/6J mouse. J Immunol (1994) 1.00
Methylprednisolone infusion therapy in rheumatoid arthritis patients. The effect on synovial fluid lymphocyte subsets and inflammatory indices. Arthritis Rheum (1986) 1.00
Failure of penicillin to eradicate the carrier state of group B Streptococcus in infants. J Pediatr (1976) 1.00
IFN-gamma induces a p91/Stat1 alpha-related transcription factor with distinct activation and binding properties. J Immunol (1995) 1.00